SCHEMBL4833052

SCHEMBL4833052

CN(CC(=O)Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C(=O)O

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ JAK2 O60674 19/20 0.72
▸ JAK3 P52333 14/20 0.70
▸ JAK1 P23458 7/20 0.70
▸ TYK2 P29597 5/20 0.68
▸ HDAC1 Q13547 3/20 0.68
▸ HDAC6 Q9UBN7 2/20 0.68
▸ HDAC3 O15379 1/20 0.62
▸ NCOR1 O75376 1/20 0.62
▸ HDAC2 Q92769 1/20 0.62
▸ HDAC8 Q9BY41 1/20 0.62
▸ PLK4 O00444 2/20 0.61
▸ CIT O14578 2/20 0.61
▸ GAK O14976 2/20 0.61
▸ ROCK2 O75116 2/20 0.61
▸ PRKD3 O94806 2/20 0.61
▸ CSNK2A2 P19784 2/20 0.61
▸ MARK3 P27448 2/20 0.61
▸ MAPK8 P45983 2/20 0.61
▸ NEK3 P51956 2/20 0.61
▸ IKBKE Q14164 2/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4377714 0.92 JAK2 (0.75) JAK2JAK3JAK1TYK2HDAC1
SCHEMBL4390314 0.88 JAK2 (0.65) JAK2JAK3JAK1TYK2HDAC1
SCHEMBL4383758 0.87 JAK2 (0.68) JAK2JAK3JAK1TYK2HDAC1
SCHEMBL4390385 0.87 JAK2 (0.80) JAK2JAK3JAK1TYK2HDAC1
SCHEMBL4583860 0.87 JAK2 (0.63) JAK2JAK3JAK1TYK2HDAC1
SCHEMBL4379953 0.86 JAK2 (0.79) JAK2JAK3JAK1TYK2HDAC1
SCHEMBL4386747 0.86 JAK2 (0.79) JAK2JAK3JAK1TYK2HDAC1
SCHEMBL4383057 0.86 JAK2 (0.73) JAK2JAK3JAK1TYK2HDAC1
SCHEMBL4383742 0.85 JAK2 (0.78) JAK2JAK3JAK1TYK2HDAC1
SCHEMBL4379094 0.85 JAK2 (0.77) JAK2JAK3JAK1TYK2HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1979329-A2 4-ARYL-2-AMINO-PYRIMIDINES OR 4-ARYL-2-AMINOALKYL-PYRIMIDINES AS JAK-2 MODULATORS AND METHODS OF USE Exelixis, Inc. (US) 2008-10-15 — — EP disclosed
WO-2007089768-A2 4-ARYL-2-AMINO-PYRIMIDINES OR 4-ARYL-2-AMINOALKYL-PYRIMIDINES AS JAK-2 MODULATORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM EXELIXIS, INC. (US) 2007-08-09 — — WO disclosed
Send feedback